<DOC>
	<DOCNO>NCT00481273</DOCNO>
	<brief_summary>This registry prospective , multi-center , observational study compile data natural history management patient receive Vidaza , provide unique insight management myelodysplastic syndrome ( MDS ) hematological disorder impact disorder patient .</brief_summary>
	<brief_title>AVIDA The Vidaza® ( Azacitidine ) Patient Registry</brief_title>
	<detailed_description />
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Azacitidine</mesh_term>
	<criteria>Patient deem appropriate treatment Vidaza® clinician , already start receive Vidaza® treatment . Patient able read speak English . Patient willing able provide inform consent . Patient agree complete patient assessment questionnaire . Patients currently treat Vidaza® . Patients concurrently participate clinical trial . Patients unwilling unable complete baseline followup questionnaire . Patients deemed inappropriate treatment Vidaza® .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>MDS</keyword>
</DOC>